Andexanet to reverse apixaban or rivaroxaban anticoagulation. Issue 9 (22nd October 2019)
- Record Type:
- Journal Article
- Title:
- Andexanet to reverse apixaban or rivaroxaban anticoagulation. Issue 9 (22nd October 2019)
- Main Title:
- Andexanet to reverse apixaban or rivaroxaban anticoagulation
- Authors:
- Chaplin, Steve
- Abstract:
- Abstract : Andexanet alfa (Ondexxya) is the first licensed antidote to the direct factor Xa inhibitors apixaban or rivaroxaban, for use when reversal of anticoagulation is needed due to life‐threatening or uncontrolled bleeding. This article summarises its indications, efficacy and safety.
- Is Part Of:
- Prescriber. Volume 30:Issue 9(2019)
- Journal:
- Prescriber
- Issue:
- Volume 30:Issue 9(2019)
- Issue Display:
- Volume 30, Issue 9 (2019)
- Year:
- 2019
- Volume:
- 30
- Issue:
- 9
- Issue Sort Value:
- 2019-0030-0009-0000
- Page Start:
- 41
- Page End:
- 42
- Publication Date:
- 2019-10-22
- Subjects:
- Chemotherapy -- Periodicals
Drugs -- Prescribing -- Periodicals
615.1 - Journal URLs:
- http://www.prescriber.co.uk/view/0/index.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/psb.1791 ↗
- Languages:
- English
- ISSNs:
- 0959-6682
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6609.700100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11905.xml